bisindolylmaleimide i has been researched along with Peripheral Nervous System Neoplasms in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Peripheral Nervous System Neoplasms: Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Svensson, K | 1 |
| Larsson, C | 1 |
1 other study available for bisindolylmaleimide i and Peripheral Nervous System Neoplasms
| Article | Year |
|---|---|
A protein kinase Cbeta inhibitor attenuates multidrug resistance of neuroblastoma cells.
Topics: Carboplatin; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Dr | 2003 |